Detalhe da pesquisa
1.
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.
Cardiovasc Diabetol
; 23(1): 104, 2024 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38504284
2.
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
Cardiovasc Diabetol
; 22(1): 59, 2023 03 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36927451
3.
Association of Low Serum Bilirubin Concentrations and Promoter Variations in the UGT1A1 and HMOX1 Genes with Type 2 Diabetes Mellitus in the Czech Population.
Int J Mol Sci
; 24(13)2023 Jun 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37445792
4.
Diagnosis and Surgical Management of Insulinomas-A 23-Year Single-Center Experience.
Medicina (Kaunas)
; 59(8)2023 Aug 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37629713
5.
ADA Standards of Medical Care in Diabetes 2022 - whats new?
Vnitr Lek
; 68(2): 85-88, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36208921
6.
Any expectations from the more powerful dulaglutide?
Vnitr Lek
; 68(2): 124-126, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36208927
7.
Diabetes, Lipids, and CV Risk.
Curr Atheroscler Rep
; 23(3): 8, 2021 01 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33464402
8.
Expert consensus on the practical aspects of the cooperation of cardiologist and diabetologist in the management of the patients with chronic heart failure and reduced ejection fraction.
Vnitr Lek
; 67(7): 404-411, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-35459358
9.
Issues for the management of people with diabetes and COVID-19 in ICU.
Cardiovasc Diabetol
; 19(1): 114, 2020 07 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32690029
10.
Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes.
Cardiovasc Diabetol
; 19(1): 185, 2020 10 23.
Artigo
Inglês
| MEDLINE | ID: mdl-33097060
11.
What is new for internists in ESC guidelines on diabetes?
Vnitr Lek
; 66(2): 111-115, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32942896
12.
Hypoglycemia in non -diabetic patients.
Vnitr Lek
; 66(7): 447-448, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33380125
13.
Diabetes management in hospital.
Vnitr Lek
; 66(2): 126-128, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32942897
14.
Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group.
Cardiovasc Diabetol
; 18(1): 30, 2019 03 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30857522
15.
Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group.
Cardiovasc Diabetol
; 17(1): 30, 2018 02 19.
Artigo
Inglês
| MEDLINE | ID: mdl-29458368
16.
Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
Pancreatology
; 17(1): 89-94, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28027898
17.
Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus.
Cent Eur J Public Health
; 25(1): 3-10, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28399348
18.
[Glycemic variability and microvascular complications of diabetes]. / Glykemická variabilita a mikrovaskulární komplikace diabetu.
Cas Lek Cesk
; 156(6): 308-313, 2017.
Artigo
Tcheco
| MEDLINE | ID: mdl-29212335
19.
Glucose variability, HbA1c and microvascular complications.
Rev Endocr Metab Disord
; 17(1): 103-10, 2016 03.
Artigo
Inglês
| MEDLINE | ID: mdl-26975588
20.
Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus.
Pancreatology
; 16(5): 839-43, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27267055